AbstractAbstract
[en] Recent interest is centred on the development of improved assays for 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) the hormonal form of vitamin D. Because radioimmunoassays have been successful when applied to the measurement of steroid hormones it seemed reasonable to use this approach to assay 1,25-(OH)2D3. These techniques have now been developed and applied to clinical studies. Clearly, the radioimmunoassay using tritium as label, is proving to be a versatile tool in the clinical study of the production and disposition of the hydroxylated vitamin D metabolites. This technique has a distinct practical advantage over existing radioreceptor assays in that antibodies provide a continuous supply of stable binding reagent whereas radioreceptor assays require preparation of intestinal binding protein from vitamin D deficient chickens. Moreover, with the radioimmunoasay approach there is considerable potential for further development. For example, by immunizing more animals with the same or different immunogens it may be possible to produce antisera with even higher affinity and with greatest structural specificity. These possibilities are now being investigated. (Auth.)
Primary Subject
Source
Bizollon, Ch.A. (ed.); 307 p; ISBN 0-444-80154-5; ; 1979; p. 161-170; Elsevier/North-Holland Biomedical Press; Amsterdam, Netherlands; 4. International Symposium on Radioimmunology; Lyon, France; 19 - 21 Apr 1979
Record Type
Book
Literature Type
Conference
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] 1α,25-Dihydroxy-25-hemisuccinate cholecalciferol has been synthesized and conjugated to bovine serum albumin. This conjugate is immunogenic; when injected into rabbits antibodies of high affinity for 1α,25-dihydroxy-cholecalciferol were obtained. Vitamin D metabolites lacking the 1α-hydroxy group were of lower cross-reactivity with the antibodies. By using these antibodies and 1α,25-[23,24-3H]dihydroxycholecalciferol as tracer a sensitive radioimmunoassay has been developed capable of detecting 20 pg of 1α,25-dihydroxycholecalciferol. (author)
Primary Subject
Record Type
Journal Article
Journal
Clinical Science and Molecular Medicine; v 54(); p. 329-332
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) has been measured on human serum by radioimmunoassay. The assay uses a high titre antiserum raised in sheep against 1,25-(OH)2D3-25-hemisuccinate, conjugated to bovine serum albumin. The sensitivity of the assay is 10 pg/tube. Other hydroxylated forms of vitamin D3 cross react with the antiserum and are therefore removed from serum extracts by chromatography on Sephadex LH 20 followed by high pressure liquid chromatography. The mean (+-SEM) serum 1,25-(OH)2D3 concentration for a group of healthy adult subjects was 41 +- 2.5 pg/ml. None was detected in anephric patients and the concentration was low or undetectable in patients with chronic renal failure. (author)
Primary Subject
Record Type
Journal Article
Journal
Clinical Endocrinology (Oxford); ISSN 0300-0664; ; v. 11(2); p. 225-234
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
No abstract available
Primary Subject
Source
Cohn, D.V. (Louisville Univ., KY (USA). Dept. of Oral Biology); Potts, J.T. Jr. (Massachusetts General Hospital, Boston (USA). Dept. of Medicine); Fujita, T. (Kobe Univ. (Japan). School of Medicine) (eds.); International congress series; no. 635; 491 p; ISBN 0-444-80590-7; ; 1984; p. 34-35; Excerpta Medica; Amsterdam (Netherlands); 8. International conference on calcium regulating hormones; Kobe-shi (Japan); 16-24 Oct 1983; short communication.
Record Type
Book
Literature Type
Conference
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue